524 related articles for article (PubMed ID: 10529073)
1. Human leukocyte antigen typing, response to neuroleptics, and clozapine-induced agranulocytosis in jewish Israeli schizophrenic patients.
Meged S; Stein D; Sitrota P; Melamed Y; Elizur A; Shmuelian I; Gazit E
Int Clin Psychopharmacol; 1999 Sep; 14(5):305-12. PubMed ID: 10529073
[TBL] [Abstract][Full Text] [Related]
2. HLA-B38 and clozapine-induced agranulocytosis in Israeli Jewish schizophrenic patients.
Valevski A; Klein T; Gazit E; Meged S; Stein D; Elizur A; Narinsky ER; Kutzuk D; Weizman A
Eur J Immunogenet; 1998 Feb; 25(1):11-3. PubMed ID: 9587740
[TBL] [Abstract][Full Text] [Related]
3. HLA-B38, DR4, DQw3 and clozapine-induced agranulocytosis in Jewish patients with schizophrenia.
Lieberman JA; Yunis J; Egea E; Canoso RT; Kane JM; Yunis EJ
Arch Gen Psychiatry; 1990 Oct; 47(10):945-8. PubMed ID: 2222133
[TBL] [Abstract][Full Text] [Related]
4. Clozapine-induced agranulocytosis in a Native American: HLA typing and further support for an immune-mediated mechanism.
Pfister GM; Hanson DR; Roerig JL; Landbloom R; Popkin MK
J Clin Psychiatry; 1992 Jul; 53(7):242-4. PubMed ID: 1639743
[TBL] [Abstract][Full Text] [Related]
5. Human leukocyte antigen system in clozapine-induced agranulocytosis.
Theodoropoulou S; Pappa H; Lykouras L; Papageorgiou G; Papasteriades C; Sakalis G
Neuropsychobiology; 1997; 36(1):5-7. PubMed ID: 9211436
[TBL] [Abstract][Full Text] [Related]
6. [Clozapine-induced agranulocytosis: genetic risk factors and an immunologic explanatory model].
Güzelcan Y; Scholte WF
Tijdschr Psychiatr; 2006; 48(4):295-302. PubMed ID: 16955993
[TBL] [Abstract][Full Text] [Related]
7. Major histocompatibility complex associations with clozapine-induced agranulocytosis. The USA experience.
Yunis JJ; Lieberman J; Yunis EJ
Drug Saf; 1992; 7 Suppl 1():7-9. PubMed ID: 1503679
[TBL] [Abstract][Full Text] [Related]
8. Clozapine treatment after agranulocytosis induced by classic neuroleptics.
Bauer M; Mackert A
J Clin Psychopharmacol; 1994 Feb; 14(1):71-3. PubMed ID: 7908676
[TBL] [Abstract][Full Text] [Related]
9. HLA associations in clozapine-induced agranulocytosis.
Yunis JJ; Corzo D; Salazar M; Lieberman JA; Howard A; Yunis EJ
Blood; 1995 Aug; 86(3):1177-83. PubMed ID: 7620171
[TBL] [Abstract][Full Text] [Related]
10. The incidence of clozapine-induced leukopenia in patients with schizophrenia at Srinagarind Hospital.
Maskasame S; Krisanaprakornkit T; Khiewyoo J
J Med Assoc Thai; 2007 Oct; 90(10):2175-80. PubMed ID: 18041439
[TBL] [Abstract][Full Text] [Related]
11. HSP70-2 9.0 kb variant is in linkage disequilibrium with the HLA-B and DRB1* alleles associated with clozapine-induced agranulocytosis.
Corzo D; Yunis JJ; Yunis EJ; Howard A; Lieberman JA
J Clin Psychiatry; 1994 Sep; 55 Suppl B():149-52. PubMed ID: 7961560
[TBL] [Abstract][Full Text] [Related]
12. Haematological side effects of clozapine: patient characteristics.
Miller PR; Cutten AE
N Z Med J; 1997 Apr; 110(1041):125-7. PubMed ID: 9140414
[TBL] [Abstract][Full Text] [Related]
13. [A case of neutropenia and agranulocytosis induced by clozapine. The importance of a drug surveillance program for their early detection].
Alfaro J; Berdichevsky E; Conte G; Tellez C
Rev Med Chil; 1994 Jun; 122(6):694-8. PubMed ID: 7732216
[TBL] [Abstract][Full Text] [Related]
14. Clozapine for refractory schizophrenia: an open study of 14 patients treated up to 2 years.
Mattes JA
J Clin Psychiatry; 1989 Oct; 50(10):389-91. PubMed ID: 2571612
[TBL] [Abstract][Full Text] [Related]
15. Long-term combination treatment with clozapine and filgrastim in patients with clozapine-induced agranulocytosis.
Hägg S; Rosenius S; Spigset O
Int Clin Psychopharmacol; 2003 May; 18(3):173-4. PubMed ID: 12702898
[TBL] [Abstract][Full Text] [Related]
16. Should chronic treatment-refractory akathisia be an indication for the use of clozapine in schizophrenic patients?
Levin H; Chengappa KN; Kambhampati RK; Mahdavi N; Ganguli R
J Clin Psychiatry; 1992 Jul; 53(7):248-51. PubMed ID: 1353492
[TBL] [Abstract][Full Text] [Related]
17. Clozapine: the commitment to patient safety.
Alphs LD; Anand R
J Clin Psychiatry; 1999; 60 Suppl 12():39-42. PubMed ID: 10372610
[TBL] [Abstract][Full Text] [Related]
18. Blood dyscrasias in clozapine-treated patients in Italy.
Lambertenghi Deliliers G
Haematologica; 2000 Mar; 85(3):233-7. PubMed ID: 10702809
[TBL] [Abstract][Full Text] [Related]
19. Hematological adverse events in clozapine-treated children and adolescents.
Gerbino-Rosen G; Roofeh D; Tompkins DA; Feryo D; Nusser L; Kranzler H; Napolitano B; Frederickson A; Henderson I; Rhinewine J; Kumra S
J Am Acad Child Adolesc Psychiatry; 2005 Oct; 44(10):1024-31. PubMed ID: 16175107
[TBL] [Abstract][Full Text] [Related]
20. NOD2/CARD15 genotype and phenotype differences between Ashkenazi and Sephardic Jews with Crohn's disease.
Karban A; Waterman M; Panhuysen CI; Pollak RD; Nesher S; Datta L; Weiss B; Suissa A; Shamir R; Brant SR; Eliakim R
Am J Gastroenterol; 2004 Jun; 99(6):1134-40. PubMed ID: 15180737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
